NeuroMax, LLC

Neuromax, llc email format

Verified email-pattern data for Neuromax, Llc is currently limited. You can still use the company insights and contact sections below.
“NeuroMax” is a private biotechnology company, founded in 2010, with the purpose to develop and launch in the Russian market innovative products for treatment of central and peripheral nervous system diseases. “NeuroMax” has been financed by Maxwell Biotech Venture Fund and has become a resident of Skolkovo Biomed Cluster as well as a participant of “Medicine of the Future” Technological platform. Projected drug, NM-IA-001, is the first and only Russian drug intended for the pathogenetic treatment of diabetic neuropathy. In preclinical proof of concept NM-IA-001 demonstrated high efficiency and a significant slowing of the disease course.

Company Details

Founded
-
Address
Moscow City, Ru
Phone
+7 (495) 726-52-53
Email
in****@****omax.ru
Industry
Biotechnology Research
HQ
Moscow City
Looking for a particular NeuroMax, LLC employee's phone or email?

Neuromax, Llc Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant